MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
attributable to catheter...
-$17,183K
(21.18%↑ Y/Y)
Net loss
attributable to catheter...
-$17,183K
(-3.24%↓ Y/Y)
Less net loss
attributable to...
-$512K
Net loss
-$17,695K
Income tax provision
(benefit)
-$1,810K
(-157.62%↓ Y/Y)
Change in fair value of
royalties payable due to...
$5,709K
(354.98%↑ Y/Y)
Interest income
$34K
(-58.02%↓ Y/Y)
Change in fair value of
convertible notes payable
$2K
Loss from operations
before income tax...
-$19,505K
(-44.46%↓ Y/Y)
Total other income
(expenses), net
$1,638K
(172.51%↑ Y/Y)
Revenues
$819K
(95.00%↑ Y/Y)
Loss on debt
extinguishment
-$3,260K
Net loss on trading
debt securities
-$564K
Interest
expense-Related Party
$186K
Interest
expense-Nonrelated Party
$95K
Other expenses, net
-$2K
(80.00%↑ Y/Y)
Operating loss
-$21,143K
(-88.05%↓ Y/Y)
Gross profit
$756K
(100.00%↑ Y/Y)
Cost of revenues
$63K
(50.00%↑ Y/Y)
Total operating
expenses
$21,899K
(88.44%↑ Y/Y)
Selling, general and
administrative
$12,075K
(6.40%↑ Y/Y)
Loss on impairment of
intangible assets
$6,995K
Acquired in-process
research and development
$1,967K
Research and development
$862K
(216.91%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Catheter Precision, Inc. (VTAK)
Catheter Precision, Inc. (VTAK)